Jasper Ridge Partners’s Rhythm Pharmaceuticals RYTM Stock Holding History

Jasper Ridge Partners’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.54M	Hold	13,845	–	–	0.03%	84
2026 Q1	$1.2M	Buy	13,845 +8,206	+146%	+$798K	0.03%	88
2025 Q4	$604K	Hold	5,639	–	–	0.01%	99
2025 Q3	$569K	Hold	5,639	–	–	0.01%	105
2025 Q2	$356K	Hold	5,639	–	–	0.01%	117
2025 Q1	$299K	Hold	5,639	–	–	0.01%	116
2024 Q4	$316K	Hold	5,639	–	–	0.01%	114
2024 Q3	$295K	Hold	5,639	–	–	0.01%	117
2024 Q2	$232K	Hold	5,639	–	–	0.01%	126
2024 Q1	$244K	Hold	5,639	–	–	0.01%	126
2023 Q4	$259K	Buy	+5,639	New	+$178K	0.01%	124

Other funds holding RYTM

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jasper Ridge Partners's RYTM Position: Q2 2026 in Review

Jasper Ridge Partners held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 13,845 shares worth $1.54M. The position accounts for 0.03% of the portfolio, ranked #84.

Jasper Ridge Partners first reported a position in RYTM in Q4 2023 and has held it in 11 quarters since. 305 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Jasper Ridge Partners held 13,845 shares of Rhythm Pharmaceuticals worth $1.54M as of Q2 2026.
Jasper Ridge Partners left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
Rhythm Pharmaceuticals made up 0.03% of Jasper Ridge Partners's portfolio in Q2 2026, its #84 holding.
Jasper Ridge Partners first reported a position in Rhythm Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
305 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.